Global Transfection Market, By Type (Transient Transfection, Stable Transfection), Methods (Non-Viral Methods, Viral Methods), CRISPR Transfection Methods (Non-Viral Methods, Viral Methods), Products (Reagent & Kits, Instrument, Software), Organism (Mammalian Cells, Plants, Fungi, Virus, Bacteria), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), Others), Application (In Vitro Application, In Vivo Application, Bioproduction, Others), Stage (Research, Preclinical, Clinical Phases, Commercial), End User (Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organization/ Contract Development and Manufacturing Organization (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, Others), Distribution Channel (Direct Tender, Retail Sales, Others) – Industry Trends and Forecast to 2031.
Transfection Market Analysis and Size
As per the March 2022 publication from the Centers for Disease Control and Prevention, chronic diseases afflict 60% of U.S. adults. The escalating prevalence, encompassing cancer and chronic lung diseases, underscores the vital role of transfection technologies in advancing treatments. Innovations addressing chronic diseases contribute to the growing healthcare demand, and the growth of the transfection market and its pivotal role in shaping future therapeutic interventions.
Data Bridge Market Research analyses that the global transfection market which was USD 1,218.58 million in 2023, is expected to reach USD 2,537.10 million by 2031, and is expected to undergo a CAGR of 9.6% during the forecast period of 2024 to 2031. This indicates that the market value. “Reagent and kits segment dominate the product segment of the global transfection market playing a crucial role in enhancing the efficiency of genetic experiments. These essential components contribute significantly to optimizing the transfection process in diverse genetic research endeavours. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Transfection Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Transient Transfection, Stable Transfection), Methods (Non-Viral Methods, Viral Methods), CRISPR Transfection Methods (Non-Viral Methods, Viral Methods), Products (Reagent and Kits, Instrument, Software), Organism (Mammalian Cells, Plants, Fungi, Virus, Bacteria), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), Others), Application (In Vitro Application, In Vivo Application, Bioproduction, Others), Stage (Research, Preclinical, Clinical Phases, Commercial), End User (Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organization/ Contract Development and Manufacturing Organization (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, Others), Distribution Channel (Direct Tender, Retail Sales, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Mirus Bio LLC. (U.S.), Promega Corporation (U.S.), Polyplus (France), Bio-Rad Laboratories, Inc. (U.S.), Merck KGaA (Germany), Lonza (Switzerland), MaxCyte. (U.S.), Altogen Biosystems (U.S.), SBS Genetech (China), FUJIFILM Irvine Scientific. (U.S.), Croda International Plc. (U.K.), PerkinElmer Inc. (U.S.), Cytiva (U.S.), Geno Technology Inc. (U.S.), R&D Systems, Inc. (U.S.), Takara Bio Inc. (Japan), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), QIAGEN (Germany), OriGene Technologies, Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Transfection is a laboratory technique involving the introduction of genetic material, such as DNA, RNA, or proteins, into eukaryotic cells. This process allows the manipulation of cellular functions for research, gene therapy, and biotechnology applications. Transfection methods include chemical, physical, or viral approaches, facilitating the study and modification of cellular processes.
Global Transfection Market Dynamics
Drivers
- Rising Demand For Gene Therapy
The escalating demand for gene therapy fuels the transfection market, propelled by increased interest and investments in research and development. Effective gene delivery methods are essential for therapeutic breakthroughs, positioning transfection technologies as pivotal tools in advancing the field and translating genetic discoveries into innovative and targeted therapeutic interventions.
- Developing Biopharmaceutical Industry For Efficient Manufacturing
The growing biopharmaceutical sector, emphasizing protein expression and production, is propelling transfection technologies. These methods play a pivotal role in optimizing cell lines for efficient biologics manufacturing. As the industry grows, the demand for advanced transfection techniques rises, contributing to the development and production of biopharmaceuticals with enhanced therapeutic potential.
Opportunities
- Technology Advancements for Efficient Delivery of Genetic Materials
The ever-advancing CRISPR technology is reshaping gene editing, offering new possibilities for transfection methods. This synergy creates opportunities for precise and efficient delivery of genetic materials, expanding applications across diverse fields. The evolving landscape signifies a potential revolution in genetic research, therapeutics, and biotechnology, driven by the synergy of CRISPR and transfection methodologies.
- Increasing Applications In Stem Cell Research
Transfection technologies play a pivotal role in stem cell research by enabling precise genetic modifications. As stem cell research advances, transfection becomes crucial for manipulating and studying stem cells. This contributes significantly to therapeutic applications, enhances the understanding of versatile cells, playing a pivotal role in driving progress in stem cell research for both therapeutic, and research purposes.
Restraints/Challenges
- Cost Constraints Limits Accessibility And Adoption
Cost constraints pose a significant barrier to the transfection market. The expenses associated with transfection reagents, equipment, and technologies hinder accessibility and adoption, especially in research settings with limited budgets. This financial challenge influences the market's growth by limiting the widespread adoption of transfection methods and technologies.
- Cytotoxicity Concerns Impact Cell Viability
Cytotoxicity concerns pose a significant challenge to the transfection market, as certain methods may adversely affect cell viability. This limitation can impede the widespread adoption of specific transfection techniques, hindering their utility and restricting their application in diverse genetic research and therapeutic endeavors.
This global transfection market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global transfection market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In September 2022, Polyplus, a prominent provider of upstream solutions for biologic and cell and gene therapy, expanded its mRNA support portfolio. The launch of in vivo-jetRNA+ transfection reagent enhances in vivo mRNA delivery with a preformed liposome. This addition signifies Polyplus' commitment to advancing efficient and precise transfection methods in the field of gene therapy
- In February 2022, Mirus Bio, a key player in delivery solutions under Gamma Biosciences, launched the TransIT-VirusGEN SELECT Transfection Kits. Specifically designed for large-scale viral vector production, these kits cater to the demands of cell and gene therapy applications, showcasing Mirus Bio's commitment to advancing efficient and scalable transfection solutions in the biotechnology industry
- In August 2021, Mirus Bio, a prominent player in transfection technologies, launched viral vector transfection kits tailored for cell and gene therapy manufacturing. These specialized transfection reagents aim to optimize the delivery of packaging and transfer vector DNA to suspension, enhancing the production of recombinant adeno-associated virus (AAV) and lentivirus (LV) vectors
- In November 2020, Thermo Fisher Scientific Inc. partnered with Northeastern University, enhancing innovation in the biopharmaceutical industry, particularly in gene and cell therapies. By consistently developing advanced reagents and techniques, the collaboration aimed to bolster sensitivity and accuracy in experiments and drug development, contributing to the production of valuable and efficient tools crucial for the transfection process
Global Transfection Market Scope
The global transfection market is segmented on the basis of type, methods, CRISPR transfection methods, products, organism, types of molecule, application, stage, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Transient Transfection
- Stable Transfection
Methods
- Non-Viral Methods
- Viral Methods
CRISPR Transfection Methods
- Non-Viral Methods
- Viral Methods
Products
- Reagent and Kits
- Instrument
- Software
Organism
- Mammalian Cells
- Plants
- Fungi
- Virus
- Bacteria
Types of Molecule
- Plasmid DNA
- Small Interfering RNA (siRNA)
- Proteins
- DNA Oligonucleotides
- Ribonucleoprotein Complexes (RNPs)
- Others
Application
- In Vitro Application
- In Vivo Application
- Bioproduction
- Others
Stage
- Research
- Preclinical
- Clinical Phases
- Commercial
End User
- Biopharma
- Contract Research Organizations (CROs)
- Contract Manufacturing Organization/ Contract Development
- Manufacturing Organization (CMOs/CDMOs)
- Academia
- Hospitals
- Clinical Labs
- Others
Distribution Channel
- Direct Tender
- Retail Sales
- Others
Global Transfection Market Regional Analysis/Insights
The global transfection market is analysed and market size insights and trends are provided by country, type, methods, CRISPR transfection methods, products, organism, types of molecule, application, stage, end user and distribution channel as referenced above.
The countries covered in the global transfection market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region holds the largest share in the global transfection market, with the U.S. leading due to a concentration of numerous companies. The robust presence of these entities contributes significantly to the region's dominance, reflecting a key stronghold in the transfection market's growth and market dynamics.
Europe dominates the global transfection market, with Germany leading the region. The country's strong emphasis on genetic research and protein production positions it as a key player. In the forecast period from 2024 to 2031, Germany's prominence is expected to contribute significantly to the continued growth and advancements in the transfection market.
Asia-Pacific is expected for the highest growth rate in the global transfection market from 2024 to 2031, driven by escalating genetic research activities. China spearheads this growth, particularly in the transient transfection segment, fueled by extensive applications in transient gene expression, underscoring the region's pivotal role in advancing transfection technologies.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The global transfection market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products global transfection market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global transfection market. The data is available for historic period 2016-2021.
Competitive Landscape and Global Transfection Market Share Analysis
The global transfection market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global transfection market.
Some of the major players operating in the global transfection market are:
- Mirus Bio LLC. (U.S.)
- Promega Corporation (U.S.)
- Polyplus (France)
- Bio-Rad Laboratories, Inc. (U.S.)
- Merck KGaA (Germany)
- Lonza (Switzerland)
- MaxCyte. (U.S.)
- Altogen Biosystems (U.S.)
- SBS Genetech (China)
- FUJIFILM Irvine Scientific. (U.S.)
- Croda International Plc. (U.K)
- PerkinElmer Inc. (U.S.)
- Cytiva (U.S.)
- Geno Technology Inc. (U.S.)
- R&D Systems, Inc. (U.S.)
- Takara Bio Inc. (Japan)
- Thermo Fisher Scientific Inc. (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- QIAGEN (Germany)
- OriGene Technologies, Inc. (U.S.)
SKU-